Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer
Clinical trial NCT02910843 · TERMINATED
Trial details
- NCT number
- NCT02910843
- Sponsor
- Swiss Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-22
- Primary completion
- 2021-12-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.